[1,4,7,10]Tetraoxacyclododecino[2,3-g]quinazolin-4-amine, N-(3-ethynylphenyl)-7,8,10,11,13,14-hexahydro- CAS NO.610798-31-7

We have been providing over 1000 products including molecular targeted anticancer drugs, cell signaling pathway

 

inhibitors, pharmaceutical intermediates, and heterocyclic compounds, and quality services including custom

 

synthesis, transfer of new drug patent and technology, technical cooperation, and process optimization.

 

 

Jinan Trio PharmaTech was founded by a core group of top overseas pharmaceutical chemists, Medical scientists and

 

business management experts, and is an enterprise of science and technology supported by the "Attracting High-

 

Level Talent Scheme" of Jinan government.

 

 

Jinan Trio PharmaTech Co., Ltd. 

 

Year Establishment: 2008

 

Location: We are located at one of the largest National Technical Integrated Drug Discovery Platforms in the High-Tech Zone of Jinan City

 

Our company was founded by a core group of top overseas pharmaceutical chemists, medical scientists business

management experts

 

We have built up solid cooperation with over twenty oversea companies over one hundred domestic companies

since the foundation

 

 

 

 

 

 

 

 

Specifications:

 

 

Name  Icotinib

 

Synonyms  N-(3-Ethynylphenyl)-7,8,10,11,13,14-hexahydro-[1,4,7,10]tetraoxacyclododecino[2,3-g]quinazolin-4-amine

 

Molecular Formula  C₂₂H₂₁N₃O₄ 

 

Molecular Weight  391.42

 

CAS Registry Number  610798-31-7

 

Density  1.31

 

Boiling point  581 ºC

 

Flash point  305 ºC

 

 

Applications:

 

 

 

Icotinib is a potent and specific epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI) with IC50 of

5 nM.